This month’s Connecting Care episode is the second in a two-part series about treatment for Hepatitis C Virus (HCV) among people with opioid use disorder.
Resources and Tools
This package is a learning tool designed for health departments and community-based organizations newly offering syringe services programs (SSPs) with the purpose of indexing the materials needed for safer injection, what to offer at a syringe services program, and how to explain what materials a
Transgender people and communities, including nonbinary people, have specific needs within harm reduction programs.
This Advisory offers guidance to providers and administrators in SUD treatment programs on screening clients for hepatitis A, hepatitis B, and hepatitis C infections, as well as action steps for the treatment and support of clients with a viral hepatitis infection and a SUD.
This technical package, a collaborative effort between CDC and NASTAD, provides a broad framework as well as evidence-informed strategies and approaches to support the planning, design, implementation, and sustainability of new and existing syringe services programs (SSPs).
This publication, part of SAMHSA's Evidence Based Resource Guide series, addresses the co-occurrence of HIV and mental illness and/or SUD.
This virtual session summary describes key takeaways from the August 2020 Let's Talk about SSPs as Essential Services conversation.
This ready-to-use slide set introduces substance use disorder providers to the issues of HIV and hepatitis C virus (HCV) screening and prevention.